{"id":69504,"date":"2024-04-20T20:40:27","date_gmt":"2024-04-20T20:40:27","guid":{"rendered":"https:\/\/www.pharmacie-vezere.com\/promotions\/?p=69504"},"modified":"2024-04-20T20:40:27","modified_gmt":"2024-04-20T20:40:27","slug":"nouveau-test-urinaire-pour-detecter-le-cancer-de-la-prostate-de-haut-grade-et-aider-les-hommes-a-eviter-les-biopsies-inutiles","status":"publish","type":"post","link":"https:\/\/www.pharmacie-vezere.com\/promotions\/nouveau-test-urinaire-pour-detecter-le-cancer-de-la-prostate-de-haut-grade-et-aider-les-hommes-a-eviter-les-biopsies-inutiles\/","title":{"rendered":"Nouveau test urinaire pour d\u00e9tecter le cancer de la prostate de haut grade et aider les hommes \u00e0 \u00e9viter les biopsies inutiles"},"content":{"rendered":"\n<p><em><strong>Les chercheurs du Centre de canc\u00e9rologie Rogel de l&#8217;Universit\u00e9 du Michigan ont d\u00e9velopp\u00e9 un nouveau test urinaire r\u00e9volutionnaire appel\u00e9 MyProstateScore2.0 (MPS2), qui am\u00e9liore de mani\u00e8re significative la d\u00e9tection du cancer de la prostate de haut grade. Cette avanc\u00e9e pourrait \u00e9viter \u00e0 de nombreux hommes des biopsies souvent invasives et inutiles.<\/strong><\/em><\/p>\n\n\n\n<p>Traditionnellement, la d\u00e9tection du cancer de la prostate s&#8217;est beaucoup appuy\u00e9e sur le test de l&#8217;antig\u00e8ne prostatique sp\u00e9cifique (PSA). Bien que ce test soit efficace pour le d\u00e9pistage initial, le PSA pr\u00e9sente des limites, notamment pour distinguer entre un cancer agressif n\u00e9cessitant un traitement imm\u00e9diat et une forme de croissance lente qui est souvent b\u00e9nigne. Le nouveau test MPS2 vise \u00e0 r\u00e9soudre ce probl\u00e8me en se concentrant sp\u00e9cifiquement sur les cancers de haut grade n\u00e9cessitant une intervention m\u00e9dicale urgente. Il analyse 18 marqueurs g\u00e9n\u00e9tiques li\u00e9s au cancer de la prostate de haut grade et am\u00e9liore ainsi le test MyProstateScore original d\u00e9velopp\u00e9 il y a pr\u00e8s d&#8217;une d\u00e9cennie.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"168\" src=\"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2024\/04\/Prostate-Cancer_1.jpg\" alt=\"\" class=\"wp-image-69506\" style=\"width:636px;height:auto\" srcset=\"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2024\/04\/Prostate-Cancer_1.jpg 300w, https:\/\/www.pharmacie-vezere.com\/promotions\/wp-content\/uploads\/2024\/04\/Prostate-Cancer_1-200x112.jpg 200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/figure>\n\n\n\n<p><strong>Approche novatrice et tests approfondis<\/strong><\/p>\n\n\n\n<p>L&#8217;\u00e9quipe de recherche, dirig\u00e9e par le Dr Arul M. Chinnaiyan et le Dr John T. Wei, a utilis\u00e9 le s\u00e9quen\u00e7age de l&#8217;ARN de plus de 58 000 g\u00e8nes pour isoler 54 candidats associ\u00e9s \u00e0 des cancers de la prostate de grade sup\u00e9rieur. Apr\u00e8s des validations compl\u00e8tes utilisant des \u00e9chantillons d&#8217;urine de pr\u00e8s de 700 patients recueillis par le Early Detection Research Network du National Cancer Institute, les chercheurs ont affin\u00e9 la liste \u00e0 18 marqueurs cl\u00e9s.<\/p>\n\n\n\n<p><strong>R\u00e9sultats cliniques impressionnants<\/strong><\/p>\n\n\n\n<p>Les tests sur plus de 800 \u00e9chantillons d&#8217;urine provenant d&#8217;un pool national diversifi\u00e9 ont montr\u00e9 l&#8217;exactitude sup\u00e9rieure de MPS2 dans l&#8217;identification des cancers plus graves (Gleason 3+4=7 ou Grade Group 2 ou plus). Plus important encore, le test exclut presque compl\u00e8tement la pr\u00e9sence de cancers de grade inf\u00e9rieur ou insignifiants (Grade Group 1), qui sont peu susceptibles de progresser ou de n\u00e9cessiter un traitement.<\/p>\n\n\n\n<p><strong>R\u00e9duction des interventions m\u00e9dicales inutiles<\/strong><\/p>\n\n\n\n<p>L&#8217;un des avantages les plus significatifs de MPS2 est son potentiel de r\u00e9duire le nombre de biopsies inutiles. Alors que le test PSA traditionnel \u00e9vitait 11 % de ces interventions, le test MPS2 pourrait en \u00e9viter jusqu&#8217;\u00e0 41 %.<\/p>\n\n\n\n<p><strong>Une nouvelle \u00e8re dans la gestion de la sant\u00e9 de la prostate<\/strong><\/p>\n\n\n\n<p>Le d\u00e9veloppement de MPS2 marque une \u00e9tape transformatrice dans la gestion de la sant\u00e9 de la prostate, offrant un outil non invasif et de haute pr\u00e9cision qui priorise la d\u00e9tection des cancers qui repr\u00e9sentent de v\u00e9ritables menaces pour la sant\u00e9 des patients. Cela rationalise non seulement le processus diagnostique mais r\u00e9duit \u00e9galement consid\u00e9rablement la charge physique et psychologique pour les patients.<\/p>\n\n\n\n<p>\u00c0 mesure que la communaut\u00e9 m\u00e9dicale continue de rechercher des options de diagnostic plus efficaces et plus respectueuses des patients, MPS2 se pr\u00e9sente comme un phare d&#8217;innovation et d&#8217;espoir pour ceux confront\u00e9s \u00e0 la menace du cancer de la prostate. Il incarne une transition vers une m\u00e9decine personnalis\u00e9e, o\u00f9 le traitement peut \u00eatre aussi cibl\u00e9 et peu invasif que possible.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les chercheurs du Centre de canc\u00e9rologie Rogel de l&#8217;Universit\u00e9 du Michigan ont d\u00e9velopp\u00e9 un nouveau test urinaire r\u00e9volutionnaire appel\u00e9 MyProstateScore2.0 (MPS2), qui am\u00e9liore de mani\u00e8re significative la d\u00e9tection du cancer de la prostate de haut grade. Cette avanc\u00e9e pourrait \u00e9viter \u00e0 de nombreux hommes des biopsies souvent invasives et inutiles. Traditionnellement, la d\u00e9tection du cancer [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[684],"tags":[],"class_list":["post-69504","post","type-post","status-publish","format-standard","hentry","category-nouvelles-pharmaceutiques"],"_links":{"self":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/comments?post=69504"}],"version-history":[{"count":1,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69504\/revisions"}],"predecessor-version":[{"id":69507,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/posts\/69504\/revisions\/69507"}],"wp:attachment":[{"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/media?parent=69504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/categories?post=69504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmacie-vezere.com\/promotions\/wp-json\/wp\/v2\/tags?post=69504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}